Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Making Whole Exome Sequencing Affordable Accessible Interpretable with Dahlia Attia-King Panacea TRANSCRIPT
Download PDFMar 20, 2024
Dahlia Attia-King, CEO of Panacea, is bringing whole exome sequencing to a broader audience and promoting the value of this data for disease prevention and making smarter lifestyle choices. She highlights the differences between whole exome sequencing and whole genome sequencing, noting that whole exome sequencing can...
Mar 20, 2024
Dahlia Attia-King, CEO of Panacea, is bringing whole exome sequencing to a broader audience and promoting the value of this data for disease prevention and making smarter lifestyle choices. She highlights the differences between whole exome sequencing and whole genome sequencing, noting that whole exome sequencing can...
Driving Growth Acceptance Therapeutic Relevance of Genetic Testing with Dr. Bill Kerr Avalon Healthcare Solutions TRANSCRIPT
Download PDFSep 20, 2023
Dr. Bill Kerr, Co-Founder and CEO of Avalon Healthcare Solutions, sheds light on the value of genetic data and is focused on getting the science of gene sequencing better understood. Genetic testing can identify opportunities for treatment and specific mutations that can lead to a more precise therapy. With the...
Sep 20, 2023
Dr. Bill Kerr, Co-Founder and CEO of Avalon Healthcare Solutions, sheds light on the value of genetic data and is focused on getting the science of gene sequencing better understood. Genetic testing can identify opportunities for treatment and specific mutations that can lead to a more precise therapy. With the...
Impact of Non-Invasive Prenatal Genetic Screening and Genetic Counseling with Sheetal Parmar Natera TRANSCRIPT
Download PDFMar 20, 2022
Sheetal Parmar is the Head of Clinical Services at Natera, a clinical genetic testing company. She draws on her experience as a prenatal genetic counselor to address the need for more accurate and available non-invasive prenatal genetic testing. This kind of information can guide women and their care teams and can also...